Mediators of Inflammation

Mediators of Inflammation / 2016 / Article
Special Issue

Control and Resolution Mechanisms of the Inflammatory Response 2016

View this Special Issue

Research Article | Open Access

Volume 2016 |Article ID 4281865 |

Yuan Qiu, Aimin Pu, Hong Zheng, Minqiang Liu, Weigang Chen, Wensheng Wang, Weidong Xiao, Hua Yang, "TLR2-Dependent Signaling for IL-15 Production Is Essential for the Homeostasis of Intestinal Intraepithelial Lymphocytes", Mediators of Inflammation, vol. 2016, Article ID 4281865, 12 pages, 2016.

TLR2-Dependent Signaling for IL-15 Production Is Essential for the Homeostasis of Intestinal Intraepithelial Lymphocytes

Academic Editor: Víctor M. Baizabal-Aguirre
Received17 Mar 2016
Revised01 Jun 2016
Accepted06 Jun 2016
Published01 Aug 2016


TLR2 signaling is related to colitis and involved in regulation of innate immunity in the intestinal tract, but the mechanisms remain unclear. The aim of this study is to investigate how TLR2 affects differentiation of intraepithelial lymphocytes (IELs) and regulates the susceptibility of colitis. IELs were isolated from the small intestine and colon of mice, respectively. The IEL phenotype, activation, and apoptosis were examined using flow cytometry and RT-PCR. IL-15 expression and IEL location were detected through immunohistochemistry. The experimental colitis was induced by administration of dextran sulfate sodium (DSS). We found that the numbers of CD8αα+, CD8αβ+, and TCRγδ+ IELs were significantly decreased in TLR2-deficient mice and the residual IELs displayed reduced activation and proliferation and increased apoptosis, accompanied with impaired IL-15 expression by intestinal epithelial cells (IECs). Further study showed that TLR2 signaling maintained the expression of IL-15 in IEC via NF-κB activation. Moreover, TLR2-deficient mice were found to be more susceptible to DSS-induced colitis as shown by the increased severity of colitis. Our results demonstrate that IECs contribute to the maintenance of IELs at least partly via TLR2-dependent IL-15 production, which provides a clue that may link IECs to innate immune protection of the host via IELs.

1. Introduction

Intestinal epithelial cells (IECs) maintain a fundamental immunoregulatory function that influences the development and homeostasis of mucosal immune cells. Interestingly, this single layer is home to an abundant population of intestinal intraepithelial lymphocytes (IELs). Though primarily comprised of CD8+ T cells, the intestinal IELs can be classified into two major subgroups [1]. One group consists of CD4+ or CD8αβ+TCRαβ+ IELs, which are known as type a IELs. Type b IELs express αβTCRs or γδTCRs with a unique coreceptor, CD8αα. About 65–75% of small intestinal IELs are type b IELs (CD8αα+TCRαβ+ and CD8αα+TCRγδ+) in mice. Most CD8αα+ IEL precursors go through a thymic stage of development and complete maturation in the intestine [2]. We and others previously reported that intestinal gut-derived cytokines are particularly important for the homeostatic proliferation and survival of these IELs. For example, specific intestinal IL-7 overexpression (IL- mice) significantly increased the number of type a IELs but did not have much effect on type b cell numbers [3]. Mice lacking the IL-15 system, including IL-15−/−, IL-15Rα−/−, and IL-15Rβ−/− mice, showed a severe reduction in CD8αα+TCRαβ+ and TCRγδ+ IELs [4, 5], combined with previous evidence showing that cytokines of the common γ-chain (γc) family (e.g., IL-7, IL-15) are critical for development of IELs and depend on γc for cellular signaling.

Toll-like receptors (TLRs) are the main pattern recognition receptors (PRRs) that can recognize pathogen-associated molecular patterns derived from a diverse collection of microbes. TLRs are inducible or constitutively expressed in different combinations throughout the whole intestinal tract by a wide variety of cell types, including IECs, myofibroblasts, and immune cells [6, 7]. TLR signaling has been shown to be involved in epithelial cell proliferation, cytokine production, and antimicrobial peptide expression [8]. Of the TLRs, TLR2 is involved in recognizing a wide range of ligands, including peptidoglycan [9], lipoteichoic acid (LTA) [10], and lipoarabinomannan [11]. A major signaling target of the TLR2 is activation of the transcription factor NF-κB, which is shuttled from the cytosol to the nucleus where it initiates expression of pro- and anti-inflammatory cytokines [12]. Indeed, our recent study has shown that the higher level of infection burden in TLR2−/− mice was closely associated with a reduction in proinflammatory cytokines in the liver [13]. Furthermore, polymorphisms in genes encoding TLR2 and NF-κB signaling proteins (NFKB1 and NFKBIA) are associated with risk of inflammatory bowel disease (IBD) [14]. Thus, it is hypothesized that TLR signaling for cytokine expression is involved in maintenance of IELs and protection of intestinal mucosa.

In this report, we found that the numbers of IELs (especially type b IELs) were reduced significantly in TLR2−/− mice and residual IELs displayed reduced activation and proliferation, accompanied with impaired expression of IL-15 in intestinal mucosa. Our results also indicate that deficiency of TLR2 contributes to the high susceptibility of mice to dextran sulfate sodium- (DSS-) induced colitis.

2. Methods

2.1. Animals

TLR2−/− mice (C57BL/6J background) were kindly provided by Wenyue Xu (Department of Pathogenic Biology, Third Military Medical University, Chongqing, China). Specific pathogen-free wild-type (WT) C57BL/6J mice were purchased from the Laboratory Animal Center of Third Military Medical University. Six- to eight-week-old, pathogen-free, male mice weighing  g were used. Mice were maintained in temperature-, humidity-, and light-controlled conditions and all studies were performed under the guidelines of the Institutional Animal Care and Use Committee of Third Military Medical University. All experimental protocols were approved by this committee. For lipoteichoic acid (LTA, Invivogen, USA) injection, LTA dissolved in PBS (5 μg/200 μL/mouse) was injected intravenously via the tail vein, and the intestinal samples were collected 24 h later.

2.2. DSS-Induced Colitis

Animals received either regular drinking water (control) or drinking water within 3% DSS (molecular weight: 36,000–50,000; MP Biomedicals, Cleveland, USA) for 7 days. Fresh DSS solution was provided every day. The mice were checked each day for morbidity and weight was recorded. Mice were sacrificed ten days after the first DSS administration. The colons were removed and colonic sections were stained with H&E.

2.3. Cell Culture

The human colon adenocarcinoma cell line SW480 was purchased from China Center for Type Culture Collection (Beijing, China). The cells were cultured in RPMI1640 supplemented with 10% fetal bovine serum (Gibco, Carlsbad, USA), 100 IU/mL penicillin, and 100 μg/mL streptomycin (Invitrogen, Carlsbad, CA). Cells were incubated in a 5% CO2 humidified incubator at 37°C. The culture medium was changed every two days.

2.4. IEL Preparation

Intestinal IEL isolation was carried out as described previously [15]. Briefly, small intestine included tissues from the duodenal bulb to the ileocecal junction. Mesenteric fat and Peyer’s patches were carefully removed. The small intestine or colon was opened longitudinally, washed in an IEL extraction buffer (1 mM EDTA, 1 mM DTT in PBS), and cut into 5 mm pieces. The pieces were stirred in the same buffer at 37°C for 25 min. The tissue suspension was filtered rapidly through a glass wool column to remove debris and centrifuged at 1500 RPM at 4°C for 5 min. Pelleted cells were suspended in 20 mL 40% isotonic Percoll (GE Healthcare Biosciences, Piscataway, USA) and centrifuged at 2200 RPM at 4°C for 22 min. The supernatant was carefully sucked off, leaving about 5 mL of solution (containing cells). And the pellet was resuspended in 2 mL Tris-NH4Cl (heated to 37°C) for red blood cell lysis. The cells were washed twice and resuspended in RPMI1640. The viability of the IELs exceeded 95%, according to trypan blue exclusion staining.

2.5. Flow Cytometric Analysis

The IELs were fluorescence-labeled with the following antibodies: CD45-PE, CD45-PerCP-Cy5.5, CD8α-APC, CD8β-FITC, CD4-PE, TCRβ-APC, TCRγδ-FITC, and CD69-FITC. All antibodies were obtained from eBioscience (San Diego, USA). 2 × 105 cells were suspended in 50 μL staining buffer (eBioscience, San Diego, USA) with saturating amounts of antibodies and incubated for 30 min at 4°C. For BrdU pulse-chase experiments, BrdU dissolved in sterile isotonic saline (10 mg/mL) was injected twice daily (0.1 mg BrdU/g body wt. per d, i.p.), and IELs were collected 24 h later. For detection of BrdU, cells were stained with FITC-conjugated anti-BrdU (BrdU Flow kit; BD Pharmingen, USA), according to the manufacturer’s instructions. The apoptotic ratios for the IELs were measured using Annexin-V-FITC/PI Apoptosis Detection Kit (eBioscience, USA) according to the manufacturer’s protocol. Data acquisition and analysis were performed with MoFlow (Beckman Coulter, US) and FlowJo (Three Star, Ashland, USA).

2.6. Histological Examination and Immunohistochemistry

Specimens for histological examination were fixed in 4% paraformaldehyde for 48 h. Representative sections of colon and jejunum were cut and embedded in paraffin. 5 μm sections were then cut and stained with H&E.

The small-intestinal tissue blocks were mounted on glass slides. The tissue sections were deparaffinised and rehydrated with xylene and graded alcohol. The primary antibodies, anti-CD3 (1 : 700; Abcam, Cambridge, MA), anti-IL-15 (1 : 200; Abcam, Cambridge, MA), and purified rabbit IgG (10 mg/mL, negative control) were incubated overnight at 4°C. Subsequently, the sections were incubated for 60 min with biotinylated goat anti-rabbit IgG (1 : 100; Wuhan Boster, China) for 60 min, followed by incubation with streptavidin-enzyme conjugate (Wuhan Boster, China). Finally, the sections were counterstained with haematoxylin. An expert observer, blinded to the experimental conditions, examined the tissue sections.

2.7. Dual-Luciferase Assay

Dual-luciferase assay for NF-κB was performed as described previously [16]. Briefly, twenty-four hours before transfection, 1 × 105 SW480 cells were seeded per well of a 24-well plate. Each pBIIx-luciferase reporter gene plasmid (100 ng, a gift from Dr. Sankar Ghosh’s Lab, Yale University) was cotransfected with TK-RL (10 ng, Promega, USA) for normalization and either 25 nmol/L of TLR2-siRNA (sense: 5′-GCCCUCUCUACAAACUUUATT -3′; antisense: 5′-UAAAGUUUGUAGAGAGGGCTT-3′) or negative control oligonucleotide (sense: 5′-UUCUCCGAACGUGUCACGUTT-3′; antisense: 5′-ACGUGACACGUUCGGAGAATT-3′). At 24 h after transfection, the cells were stimulated with TLR2 agonist, LTA (500 ng/mL), for 6 h. Then, cell extracts were obtained using the dual-luciferase assay kit according to the manufacturer’s protocol.

2.8. Quantitative Real-Time PCR

Total RNA was extracted from isolated IELs using TRIzol (Invitrogen, Carlsbad, CA). RNA was reverse-transcribed into complementary DNA (cDNA) using a SuperScript First-Strand Synthesis System RT-PCR kit (Invitrogen). This cDNA was used as a template for the amplification of KGF, IL-2, IL-10, RegIIIγ, and β-actin. Quantitative PCR was performed by SYBR Premix Ex TaqTM II (TaKaRa, Japan) using an ABI 7500 (Applied Biosystems, USA). The primers selected are as follows: KGF, F: CGCAAATGGATACTGACACG, R: GGGCTGGAACAGTTCACACT; IL-2, F: CCTGGAGCAGCTGTTGATGG, R: CAGAACATGCCGCAGAGGTC; IFN-γ, F: TCAAGTGGCATAGATGTGGAAGAA, R: TGGCTCTGCAGGATTTTCATG; RegIIIγ, F: TTCCTGTCCTCCATGATCAAAA, R: CATCCACCTCTGTTGGGTTCA; IL-7, F: TCTGCTGCCTGTCACATCATCT, R: AAGTTTGGTTCATTATTCGGG; IL-15, F: ATGTTCATCAACACGTCCTGACT, R: GCAGCAGGTGGAGGTACCTTAA; β-actin, F: CTTCTTTGCAGCTCCTTCGTT, R: AGGAGTCCTTCTGACCCATTC. The expression of each gene was normalized to β-actin expression in the individual samples.

2.9. Statistical Analysis

All data are expressed as means ± SD. Differences were analyzed by Student’s -test (with 95% confidence interval). values < 0.05 were considered significant.

3. Results

3.1. TLR2 Deficiency Results in the Loss of IELs

To investigate whether TLR2 signaling has an impact on the homeostasis of IELs, we first examined the numbers of IELs in TLR2−/− mice. The number of IELs was analyzed by flow cytometry. The total number of IELs in TLR2−/− mice was reduced significantly in the small intestine and colon, respectively (Figures 1(a) and 1(b)). Immunohistochemistry was used to detect and localize the IELs, and most of these cells expressed CD3. In situ staining for CD3 confirmed that IELs were tightly interdigitated with IECs at the basolateral face (Figure 1(c)). Consistent with flow cytometry, there was a striking loss of CD3-positive cells in the small intestine in the absence of TLR2 compared with WT mice (Figure 1(c)).

3.2. Type b IELs Are Dramatically Decreased in TLR2−/− Mice

To better understand the changes occurring in the IELs after TLR2 knockout, a phenotype analysis was performed using flow cytometry. Typical results are presented in Figures 2(a) and 2(b), and the absolute numbers of IEL subsets are summarized in Figures 2(c) and 2(d). Analysis of small intestinal IELs in TLR2−/− mice revealed that the unconventional CD8αα+ (approximately 3.3-fold) and TCRγδ+ (approximately 3.9-fold) IELs were dramatically reduced and the CD8αβ+ IEL subset was significantly reduced (approximately 1.1-fold). There was no significant difference in the number of CD4+ IELs in small intestine between TLR2−/− and WT mice, although their proportion relatively was increased in TLR2−/− mice. Similar results were also observed in the colon of TLR2−/− mice. However, CD4+ IELs from colon were significantly reduced in TLR2−/− mice. These data thus indicate a critical and selective role for TLR2 in the homeostasis of IELs.

3.3. IELs Display Reduced Proliferation and Increased Apoptosis in TLR2−/− Mice

To investigate the contribution of TLR2-dependent proliferative and cell survival signals in IELs, we assessed their proliferative capacity by incorporation of BrdU in vivo. CD8αα+ IELs showed poorer proliferation in TLR2−/− mice, whereas the CD8αβ+ IELs were normal (Figure 3(b)). We next examined whether TLR2 deletion affected the apoptosis of IELs. The residual IELs showed higher apoptosis in TLR2−/− mice (Figure 3(c)). IELs are T cells that exist in some intermediate stage of activation, and CD69 expression might reflect the activated nature of IELs. Histogram showed a decrement in the expression of CD69 on the IELs from TLR2−/− mice (Figure 3(a)). A panel of cytokines was selected to represent the activities responsible for IEL activation and intestine protection. Results are shown in Figure 3(d). IEL cytokine expressions were significantly altered after TLR2 knockout. The results suggest that IL-2, IFN-γ, and RegIIIγ mRNA expression in TLR2−/− IELs significantly decreased. However, KGF showed no significant difference between WT group and TLR2−/− group (Figure 3(d)).

3.4. TLR2 Signaling in the IECs Maintains IL-15 Expression

We and others have previously reported that IL-7 and IL-15 play critical roles in the development of IELs [17]. We next examined IL-7 and IL-15 mRNA in the mucosa of jejunum by RT-PCR. Interestingly, the basal or LTA-induced expression of IL-15 in mucosa was decreased when TLR2 was absent (Figure 4(a)). However, the defect in IL-7 mRNA expression in TLR2−/− mice was limited (Figure 4(a)). We also used immunohistochemistry to confirm the RT-PCR results suggesting that TLR2-driven signals regulated the expression of IL-15 in intestinal mucosa (Figure 4(b)). It is known that NF-κB binding site is essential for transcriptional activation of the IL-15 gene. To test whether TLR2 agonist could activate signaling pathway in intestinal epithelial cell line, NF-κB reporter activity was assessed after the TLR2 siRNA or mock siRNA-transfected SW480 was stimulated with LTA, respectively. As shown in Figure 4(c), LTA could induce high levels of NF-κB reporter activity, whereas the response of TLR2 siRNA group to LTA was largely suppressed. Thus, our data strongly suggest that TLR2 signaling might maintain the expression of IL-15 in IEC via NF-κB activation.

3.5. TLR2 Deficiency Increases Epithelial Immunopathology

Loss of type b IELs in mice aggravated colitis in several animal models and resulted in impaired ability to repair damaged epithelia. In order to address the consequences of TLR2 deficiency for intestinal physiology, we employed DSS-induced colitis. The severity of the tissue damage in TLR2-deficient colons was illustrated in histological sections, showing diffuse lamina propria and increased destruction of colonic epithelium but reduced immune cell infiltration (Figure 5(a)). The overall mortality rate was 80% in DSS-TLR2−/− mice versus 10% in DSS-WT mice (Figure 5(b)). Compared with WT controls, TLR2 knockout animals lost weight more rapidly, to a greater extent, and failed to gain weight during the course of the 9-day experiment (Figure 5(c)). These data suggest that TLR2 deficiency contributes to the impaired innate immune defense and high susceptibility to colitis in these mice.

4. Discussion

Triggering of PRRs in IECs leads to the expression of immune modulators, which have an impact on the regulation of the adjacent immune cells and are necessary to maintain intestinal mucosa barrier [18]. As IECs have long been recognized as a source of IL-15 in the intestines and are adjacent to IELs, this study determined whether the TLRs on IECs are associated with the homoeostasis of IELs through an IL-15-dependent manner. We found that TLR2-dependent signaling in IECs played an important role in development of IELs (especially CD8αα+TCRαβ+ and TCRγδ+ IELs), and the signaling was essential in transcriptional activation of IL-15 via NK-κB. Furthermore, we have shown that loss of IELs contributes to the high susceptibility of TLR2−/− mice to DSS-induced colitis.

Although the study of TLR pathways in haematopoietic cells has mostly focused on their proinflammatory properties, their role in maintaining IELs homeostasis and immune tolerance has emerged as a major component of their function in IECs. In the mouse small intestine, the expression of TLR2 is found in 3 IEC lineages: enterocytes, Paneth cells, and enteroendocrine cells [19, 20]. In addition to regional localization, TLR2 expression in the intestine is also thought to be regulated spatially. TLR2 expression is found on both apical and basolateral sides of the follicle-associated epithelium but only the apical side of the villous IECs [7]. Taken together, the localization and expression of TLR2 suggest that the molecular patterns that are actually recognized by TLR2 in the intestine are generally not from pathogens but from the commensal flora. Thus, we focus on the role of TLR2 in shaping the repertoire of IELs in the small intestine and colon. In this study, we showed that the total number of IELs in TLR2−/− mice was reduced significantly in the small intestine and colon as compared with WT mice. Moreover, TLR2−/− mice showed dramatically reduced numbers of CD8αα+TCRαβ+ and TCRγδ+, similar to the proportions found in IL-15−/− mice [4]. However, CD8αβ+ IELs were moderately reduced in TLR2−/− mice. These results suggest that type b IELs are more sensitive to TLR2 deficiency. Interestingly, Shin and Iwasaki found that CD8αβ+ tissue-resident memory T cells (belong to type a IEL) expressed less IL-15Rb [21]. Based on these facts, we speculated that type b IELs may express more IL-15R compared to type a IELs. Moreover, Yu et al. found that the CD8αα+TCRαβ+ and TCRγδ+ IELs were selectively decreased in myeloid differentiation factor 88- (MyD88-) deficient mice [22]. And we all know that the MyD88-dependent pathway is utilized by all TLRs except TLR3. Here, we identify previously unappreciated TLR2-mediated signaling necessary for development or maintenance of IEL populations. Consistent with an immune-modulator role of TLR, ~1.8% of all murine transcripts were affected significantly by TLR2 deletion, a number of which correlated with immune processes changes [23]. However, our data showed that the CD8αα+TCRαβ+ and CD8αα+TCRγδ+ IEL subsets did not completely disappear in TLR2−/− mice. This may be because the expression of IL-15 in intestinal mucosa was reduced but not completely lost in TLR2−/− mice, which is consistent with our immunohistochemistry findings (Figure 4(b)). Alternatively, the IELs may depend for their development and maintenance on factors other than IL-15, such as IL-2 and IL-7 [24, 25].

Homeostasis of peripheral lymphocytes is regulated by proliferation and apoptosis. Lai et al. reported that IL-15 did not affect IEL development in the thymus but regulated homeostasis of IELs in the intestine [26]. It has been shown that intestinal IL-15 supports CD8αα+ IELs survival through the activation of the PI3K-Akt-ERK pathway to upregulate Bcl-2 and Mcl-1 [27]. In the present study, we showed that the residual IELs displayed increased apoptosis in TLR2−/− mice. In addition to its effects on IEL survival, IL-15 is also known for the ability to enhance proliferation of isolated IELs in vitro [28]. To investigate the contribution of TLR2-dependent proliferative signals in IELs, we assessed their proliferative capacity by incorporation of BrdU in vivo. The CD8αα+ IELs showed poorer proliferation in TLR2−/− mice, whereas the CD8αβ+ IELs held the normal capacity. Therefore, these results suggest that IEC contributes to the maintenance of IELs at least partly via TLR2-dependent IL-15 production. Unlike T cells in other peripheral immune compartments, IELs express some markers of activated T cells, such as the CT antigen (in mice) and CD69, suggesting that they constitute a large population of “partially activated” effector cells [29]. Moreover, the majority of IELs can secrete epithelial growth factors and produce Th1 cytokines and antimicrobial peptides, such as RegIIIγ [30]. In this study, TLR2−/− mice had a lower level of IEL activation than WT mice. Additionally, the residual IELs in TLR2−/− mice expressed a reduced level of IFN-γ, IL-2, and RegIIIγ. Consistent with our study, other researchers have found that commensal bacteria are required for DSS-induced expression of proinflammatory cytokines and the antibacterial lectin RegIIIγ in IELs [31]. Furthermore, TCRγδ+ IELs activation was found to be dependent on epithelial cell-intrinsic MyD88 [22]. Thus, the above lines of evidence indicate that IECs supply microbe-dependent cues to IELs via TLRs.

IL-15 was found to be produced only by limited populations of cells, such as dendritic cells and epithelial cells, but not by activated T cells. And perhaps, more importantly, Ma et al. demonstrated that transpresentation of IL-15 by IECs alone is completely sufficient to direct the IL-15-mediated development of CD8αα+ IELs [4]. We thus investigated whether TLR2 signaling affected the production of IL-15 by IECs. Immunohistochemistry results showed that IL-15 is mainly expressed in intestinal epithelium in the basal condition. As expected, the basal expression of IL-15 in epithelium was decreased when TLR2 was absent. It is known that NF-κB binding site is essential for transcriptional activation of the IL-15 gene [32]. In this regard, we observed that the TLR2 siRNA decreased the NF-κB gene reporter activity in response to LTA (TLR2 agonist) in intestinal epithelial cell line SW480. Therefore, as discussed above, it is now apparent that TLR2-MyD88-dependent signaling is important for transcriptional activation of IL-15 gene in IEC and consequently for development and/or maintenance of IEL populations. More researches need to be done for confirming this pathway in IEC and defining the commensal bacterial species that elicit this effect.

Although the etiology of IBD is poorly understood, increasing evidence suggests that IBD is caused in genetically susceptible individuals by a dysregulated mucosal immune response to intestinal microorganisms. Advances risen from genome-wide association studies (GWAS) and immunological studies have recently moved the focus of IBD pathogenesis onto mucosal innate immune responses, such as epithelial barrier integrity, innate microbial sensing, autophagy, and unfolded protein response, as central pathogenic pathways in IBD [33]. IECs from patients with IBD have higher expression of TLRs, especially TLR4, and similar or lower expression of TLR2, TLR3, TLR5, and TLR9 than IECs from control individuals [7]. Systemic administration of the TLR2 ligand tripalmitoyl-S-glyceryl cysteine-serine4-lysine (Pam3CSK4) protects against DSS-induced colitis [34]. In this study, TLR2−/− mice were susceptible to the colitis induced by DSS. The above results suggest that IELs dysregulation caused by loss of TLR2 may favor the onset of colitis. Indeed, data from our previous study suggest that loss of CD8αα+TCRαβ+ and TCRγδ+ aggravates colitis in the mouse model [35]. However, we also cannot ignore the emerging role of TLR2 in protecting TJ-associated integrity and enhancing transepithelial resistance of the enterocyte barrier [34].

5. Conclusion

Collectively, TLR2-dependent signaling is important in keeping the number of the IEL populations in the basal condition. Mice with TLR2 deletion lacked IELs, especially the CD8αα+ IELs (type b IELs), in the small intestine and colon. The residual IELs displayed reduced proliferation and activation and increased apoptosis in TLR2−/− mice, accompanied with impaired IL-15 expression by IEC. Moreover, our results also indicate that deficiency of TLR2 contributes to the high susceptibility of mice to DSS-induced colitis. These results suggest that TLR2-dependent signaling for IL-15 production from interaction between commensal bacteria and IEC plays an important role in maintenance of homeostasis of IEL.

Competing Interests

The authors declare no competing interests regarding the publication of this paper.

Authors’ Contributions

Yuan Qiu and Aimin Pu contributed equally to this work.


This work was supported by funding from the National Natural Science Foundation of China (NSFC 81500405 to Yuan Qiu, NSFC 81330013 to Hua Yang) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT 13051) to Hua Yang.


  1. H. Cheroutre, F. Lambolez, and D. Mucida, “The light and dark sides of intestinal intraepithelial lymphocytes,” Nature Reviews Immunology, vol. 11, no. 7, pp. 445–456, 2011. View at: Publisher Site | Google Scholar
  2. L. Peaudecerf, P. Ribeiro Dos Santos, A. Boudil, S. Ezine, N. Pardigon, and B. Rocha, “The role of the gut as a primary lymphoid organ: CD8αα intraepithelial T lymphocytes in euthymic mice derive from very immature CD44+ thymocyte precursors,” Mucosal Immunology, vol. 4, no. 1, pp. 93–101, 2011. View at: Publisher Site | Google Scholar
  3. H. Yang, B. Madison, D. L. Gumucio, and D. H. Teitelbaum, “Specific overexpression of IL-7 in the intestinal mucosa: the role in intestinal intraepithelial lymphocyte development,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 294, no. 6, pp. G1421–G1430, 2008. View at: Publisher Site | Google Scholar
  4. L. J. Ma, L. F. Acero, T. Zal, and K. S. Schluns, “Trans-presentation of IL-15 by intestinal epithelial cells drives development of CD8αα IELs,” The Journal of Immunology, vol. 183, no. 2, pp. 1044–1054, 2009. View at: Publisher Site | Google Scholar
  5. M. K. Kennedy, M. Glaccum, S. N. Brown et al., “Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice,” The Journal of Experimental Medicine, vol. 191, no. 5, pp. 771–780, 2000. View at: Publisher Site | Google Scholar
  6. E. Cario, “Toll-like receptors in inflammatory bowel diseases: a decade later,” Inflammatory Bowel Diseases, vol. 16, no. 9, pp. 1583–1597, 2010. View at: Publisher Site | Google Scholar
  7. M. T. Abreu, “Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function,” Nature Reviews Immunology, vol. 10, no. 2, pp. 131–143, 2010. View at: Publisher Site | Google Scholar
  8. S. Frosali, D. Pagliari, G. Gambassi, R. Landolfi, F. Pandolfi, and R. Cianci, “How the intricate interaction among toll-like receptors, microbiota, and intestinal immunity can influence gastrointestinal pathology,” Journal of Immunology Research, vol. 2015, Article ID 489821, 12 pages, 2015. View at: Publisher Site | Google Scholar
  9. R. Schwandner, R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning, “Peptidoglycan-and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2,” The Journal of Biological Chemistry, vol. 274, no. 25, pp. 17406–17409, 1999. View at: Publisher Site | Google Scholar
  10. N. W. J. Schröder, S. Morath, C. Alexander et al., “Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved,” The Journal of Biological Chemistry, vol. 278, no. 18, pp. 15587–15594, 2003. View at: Publisher Site | Google Scholar
  11. D. M. Underhill, A. Ozinsky, K. D. Smith, and A. Aderem, “Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 25, pp. 14459–14463, 1999. View at: Publisher Site | Google Scholar
  12. F. Sandor, E. Latz, F. Re et al., “Importance of extra- and intracellular domains of TLR1 and TLR2 in NFκB signaling,” Journal of Cell Biology, vol. 162, no. 6, pp. 1099–1110, 2003. View at: Publisher Site | Google Scholar
  13. H. Zheng, Z. Tan, T. Zhou et al., “The TLR2 is activated by sporozoites and suppresses intrahepatic rodent malaria parasite development,” Scientific Reports, vol. 5, Article ID 18239, 2015. View at: Publisher Site | Google Scholar
  14. S. Bank, P. Skytt Andersen, J. Burisch et al., “Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort,” PLoS ONE, vol. 9, no. 6, Article ID e98815, 2014. View at: Publisher Site | Google Scholar
  15. H. Yang, X. Sun, E. Q. Haxhija, and D. H. Teitelbaum, “Intestinal epithelial cell-derived interleukin-7: a mechanism for the alteration of intraepithelial lymphocytes in a mouse model of total parenteral nutrition,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 292, no. 1, pp. G84–G91, 2007. View at: Publisher Site | Google Scholar
  16. Y. Qiu, Y. Ding, L. Zou et al., “Divergent roles of amino acid residues inside and outside the BB loop affect human toll-like receptor (TLR)2/2, TLR2/1 and TLR2/6 responsiveness,” PLoS ONE, vol. 8, no. 4, Article ID e61508, 2013. View at: Publisher Site | Google Scholar
  17. Y. Qiu, W. Wang, W. Xiao, and H. Yang, “Role of the intestinal cytokine microenvironment in shaping the intraepithelial lymphocyte repertoire,” Journal of Leukocyte Biology, vol. 97, no. 5, pp. 849–857, 2015. View at: Publisher Site | Google Scholar
  18. L. W. Peterson and D. Artis, “Intestinal epithelial cells: regulators of barrier function and immune homeostasis,” Nature Reviews Immunology, vol. 14, no. 3, pp. 141–153, 2014. View at: Publisher Site | Google Scholar
  19. E. Cario, I. M. Rosenberg, S. L. Brandwein, P. L. Beck, H.-C. Reinecker, and D. K. Podolsky, “Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing toll-like receptors,” The Journal of Immunology, vol. 164, no. 2, pp. 966–972, 2000. View at: Publisher Site | Google Scholar
  20. M. Palazzo, A. Balsari, A. Rossini et al., “Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion,” The Journal of Immunology, vol. 178, no. 7, pp. 4296–4303, 2007. View at: Publisher Site | Google Scholar
  21. H. Shin and A. Iwasaki, “Tissue-resident memory T cells,” Immunological Reviews, vol. 255, no. 1, pp. 165–181, 2013. View at: Publisher Site | Google Scholar
  22. Q. Yu, C. Tang, S. Xun, T. Yajima, K. Takeda, and Y. Yoshikai, “MyD88-dependent signaling for IL-15 production plays an important role in maintenance of CD8αα TCRαβ and TCRγδ intestinal intraepithelial lymphocytes,” Journal of Immunology, vol. 176, no. 10, pp. 6180–6185, 2006. View at: Publisher Site | Google Scholar
  23. R. Kellermayer, S. E. Dowd, R. A. Harris et al., “Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice,” The FASEB Journal, vol. 25, no. 5, pp. 1449–1460, 2011. View at: Publisher Site | Google Scholar
  24. Y. Qiu, K. Peng, M. Liu, W. Xiao, and H. Yang, “CD8αα TCRαβ intraepithelial lymphocytes in the mouse gut,” Digestive Diseases and Sciences, vol. 61, no. 6, pp. 1451–1460, 2016. View at: Publisher Site | Google Scholar
  25. D. Isakov, A. Dzutsev, J. A. Berzofsky, and I. M. Belyakov, “Lack of IL-7 and IL-15 signaling affects interferon-γ production by, more than survival of, small intestinal intraepithelial memory CD8 + T cells,” European Journal of Immunology, vol. 41, no. 12, pp. 3513–3528, 2011. View at: Publisher Site | Google Scholar
  26. Y.-G. Lai, M.-S. Hou, Y.-W. Hsu et al., “IL-15 does not affect IEL development in the thymus but regulates homeostasis of putative precursors and mature CD8αα+ IELs in the intestine,” The Journal of Immunology, vol. 180, no. 6, pp. 3757–3765, 2008. View at: Publisher Site | Google Scholar
  27. Y.-G. Lai, M.-S. Hou, A. Lo et al., “IL-15 modulates the balance between Bcl-2 and Bim via a Jak3/1-PI3K-Akt-ERK pathway to promote CD8αα+ intestinal intraepithelial lymphocyte survival,” European Journal of Immunology, vol. 43, no. 9, pp. 2305–2316, 2013. View at: Publisher Site | Google Scholar
  28. K. Inagaki-Ohara, H. Nishimura, A. Mitani, and Y. Yoshikai, “Interleukin-15 preferentially promotes the growth of intestinal intraepithelial lymphocytes bearing γδ T cell receptor in mice,” European Journal of Immunology, vol. 27, no. 11, pp. 2885–2891, 1997. View at: Publisher Site | Google Scholar
  29. D. Montufar-Solis, T. Garza, and J. R. Klein, “T-cell activation in the intestinal mucosa,” Immunological Reviews, vol. 215, no. 1, pp. 189–201, 2007. View at: Publisher Site | Google Scholar
  30. K. Fukatsu, “Impact of the feeding route on gut mucosal immunity,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 17, no. 2, pp. 164–170, 2014. View at: Publisher Site | Google Scholar
  31. A. S. Ismail, C. L. Behrendt, and L. V. Hooper, “Reciprocal interactions between commensal bacteria and γδ intraepithelial lymphocytes during mucosal injury,” Journal of Immunology, vol. 182, no. 5, pp. 3047–3054, 2009. View at: Publisher Site | Google Scholar
  32. J. Washizu, H. Nishimura, N. Nakamura, Y. Nimura, and Y. Yoshikai, “The NF-κB binding site is essential for transcriptional activation of the IL-15 gene,” Immunogenetics, vol. 48, no. 1, pp. 1–7, 1998. View at: Publisher Site | Google Scholar
  33. Y.-Z. Zhang and Y.-Y. Li, “Inflammatory bowel disease: pathogenesis,” World Journal of Gastroenterology, vol. 20, no. 1, pp. 91–99, 2014. View at: Publisher Site | Google Scholar
  34. E. Cario, G. Gerken, and D. K. Podolsky, “Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function,” Gastroenterology, vol. 132, no. 4, pp. 1359–1374, 2007. View at: Publisher Site | Google Scholar
  35. T. Ji, C. Xu, L. Sun et al., “Aryl hydrocarbon receptor activation down-regulates IL-7 and reduces inflammation in a mouse model of DSS-induced colitis,” Digestive Diseases and Sciences, vol. 60, no. 7, pp. 1958–1966, 2015. View at: Publisher Site | Google Scholar

Copyright © 2016 Yuan Qiu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.